Sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation and hepatocellular carcinoma prognosis. Hendryx M, Dong Y, Ndeke JM, Luo J, et al. PLoS One 2022;17:e0274519.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hendryx M, Dong Y, Ndeke JM, Luo J, et al. Sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation and hepatocellular carcinoma prognosis. PLoS One 2022;17:e0274519.
PMID: 36094949